Scarica l'app Stockscreener
588.29
1.28%
-7.60
Dopo l'orario di chiusura:
587.80
-0.49
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$595.89
Aprire:
$592.11
Volume 24 ore:
1.06M
Relative Volume:
0.48
Capitalizzazione di mercato:
$217.52B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
32.34
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
-0.96%
1M Prestazione:
+10.15%
6M Prestazione:
+16.53%
1 anno Prestazione:
+21.29%
Intervallo 1D:
$587.51
$594.74
Intervallo di 1 settimana:
$587.51
$606.75
Portata 52W:
$435.27
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Wealth Enhancement Advisory Services LLC - MarketBeat
QRG Capital Management Inc. Raises Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Brown Shipley& Co Ltd Acquires New Shares in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Brookstone Capital Management Has $993,000 Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fenimore Asset Management Inc Invests $3.06 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Envetec Appoints Patrick S. Jones as Independent Director - Yahoo Finance
Thermo Fisher EVP Michael D. Shafer Reports Stock Option Exercises and Sales on August 11, 2026 - kalkinemedia.com
Fund Update: 3,029,037 THERMO FISHER SCIENTIFIC (TMO) shares added to DODGE & COX portfolio - Quiver Quantitative
Michael Shafer Sells 25,500 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
Thermo Fisher Scientific Insider Sold Shares Worth $15,300,000, According to a Recent SEC Filing - marketscreener.com
Thermo Fisher Scientific (TMO) EVP exercises options, then sells 25,500 shares - Stock Titan
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now? - The Motley Fool
Axinn Advises Thermo Fisher Scientific On Completed $1.075 Billion Sale Of Microbiology Business To Astorg - Mondaq
Thermo Fisher vende su división de microbiología por más de $1,000 millones - WFMZ.com
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm - medtechdive.com
Thermo Fisher sells microbiology business for $1.08 billion - wfmz.com
Y Intercept Hong Kong Ltd Cuts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fund Update: 22,749 THERMO FISHER SCIENTIFIC (TMO) shares added to Magellan Asset Management Ltd portfolio - Quiver Quantitative
Howland Capital Management LLC Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples - BioPharma APAC
Is Thermo Fisher Scientific Inc. (NYSE:TMO) Potentially Undervalued? - Moomoo
Thermo Fisher Beat Estimates by $300 Million in Q2. Is the Recovery Finally Here? - TIKR.com
Astorg VIII, SLP, managed by Astorg Asset Management S A.R.L. completed the acquisition of Global Microbiology Business from Thermo Fisher Scientific Inc.. - marketscreener.com
Astorg Acquires Thermo Fisher Microbiology Business for $1.075B - Contract Pharma
Thermo Fisher completes sale of microbiology unit for $1.08b By Investing.com - Investing.com Canada
Thermo Fisher completes sale of microbiology unit for $1.08b - Investing.com
Thermo Fisher Scientific Closes Microbiology Unit Sale to Astorg - marketscreener.com
Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist - Yahoo Finance
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg - Business Wire
Northside Capital Management LLC Raises Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Hudson Value Partners LLC Purchases 3,317 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Astorg completes buyout of Thermo Fisher’s microbiology business - pehub.com
Annex Advisory Services LLC Buys 2,756 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher advances proteomics-enabled Parkinson’s precision medicine - BioSpectrum Asia
Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)? - finance.yahoo.com
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga
Thermo Fisher Says India Is One Of Its Fastest-Growing Markets - Benzinga
Witnessing An Insider Decision, Joseph R Holmes Exercises Options Valued At $120K At Thermo Fisher Scient - Benzinga
Thermo Fisher Scientific Completes Olink Explore HT Proteomic Analysis Of Approximately 5,500 Parkinson?s Precision Medicine Initiative Research Samples - marketscreener.com
Handelsbanken Fonder AB Lowers Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Marc Casper Sells 4,608 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) CAO Joseph Holmes Sells 420 Shares - MarketBeat
Thermo Fisher chairman & CEO Marc Casper sells $2.86m in shares - Investing.com
Thermo Fisher (TMO) CEO Marc N. Casper exercises options and sells 4,883 shares - Stock Titan
How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform - Yahoo Finance
Thermo Fisher Scientific Inc Investor Day Transcript - GuruFocus
Thermo Fisher Scientific Inc. $TMO Shares Sold by Franklin Street Advisors Inc. NC - MarketBeat
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and Potential for Growth in Healthcare - DirectorsTalk Interviews
Thermo Fisher Targets More than 15% Growth in India Customer Base - marketscreener.com
Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost - Reuters
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):